News Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 16:55:00 21/01/2026 GMT			After hours 18:27:19
78.40 ^EUR	+0.47%		78.62	+0.29%

12:01pm	Sanofi Kept at Buy as Berenberg Highlights Drugmaker's Top-tier Topline, Deals Firepower	MT
01-20	Global drugmakers rush to boost US presence as tariff threat looms	RE

12:01pm	Sanofi Kept at Buy as Berenberg Highlights Drugmaker's Top-tier Topline, Deals Firepower	MT
01-20	Global drugmakers rush to boost US presence as tariff threat looms	RE
01-20	Novavax signs licensing agreement with Pfizer for vaccine development	RE
01-16	Agomab Therapeutics files for US IPO - SEC filing	RE
01-16	Arch Biopartners Inc. Announces Appointment of Patrick Vink as Chairman of the Board and Retirement of Claude Allary from the Board of Directors	CI
01-16	UBS Downgrades Sanofi, Citing Lack of "Pipeline"
01-16	SANOFI : UBS gives a Neutral rating	ZD
01-16	European Markets Lack Direction
01-16	SANOFI : Deutsche Bank maintains a Buy rating	ZD
01-15	Sector Update: Health Care Stocks Softer Late Afternoon	MT
01-15	Sector Update: Health Care Stocks Softer in Afternoon Trading	MT
01-15	European Stocks Close Mostly Higher in Thursday Trading; GDP Expands in Germany, UK	MT
01-15	Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	MT
01-15	Global markets live: Microsoft, Morgan Stanley, Citigroup, Disney, Spotify…
01-15	Sanofi, Disc Medicine Drug Reviews Delayed as FDA Flags Safety, Efficacy Issues	MT
01-15	Sanofi Gets China Approval for 2 Medicines	MT
01-15	SANOFI : Barclays sticks Neutral	ZD
01-15	SANOFI : Goldman Sachs remains Neutral	ZD
01-15	US FDA delays two drug reviews in new voucher program after safety, efficacy concerns	RE
01-15	Fda pushes back review of Sanofi's diabetes drug Tzield and Disc Medicine's blood disorder drug -documents	RE
01-15	Sanofi Announces Approval of Myqorzo and Redemplo in China	CI
01-15	The National Medical Products Administration in China Approves Two Sanofi-Licensed Innovative Medicines for Treatment	CI
01-15	Two Sanofi Drugs Approved in China
01-15	Sanofi Obtains Approvals for Myqorzo, Redemplo in China	MT
01-15	Sanofi: Myqorzo and Redemplo Approved in China	RE